相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
B. Jonsson et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Partial adherence: a new perspective on health economic assessment in osteoporosis
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRA®
John A. Kanis et al.
BONE (2010)
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
Alexandra Papaioannou et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
The diagnosis of osteoporosis
John A. Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
FRAXA® assessment of osteoporotic fracture probability in Switzerland
K. Lippuner et al.
OSTEOPOROSIS INTERNATIONAL (2010)
The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis
F. Borgstrom et al.
OSTEOPOROSIS INTERNATIONAL (2010)
The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAXA®
F. Borgstrom et al.
OSTEOPOROSIS INTERNATIONAL (2010)
An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women
John A. Kanis et al.
Archives of Osteoporosis (2010)
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®
John A. Kanis et al.
BONE (2009)
FRAX (R) and its applications to clinical practice
John A. Kanis et al.
BONE (2009)
Assessment of fracture risk
John A. Kanis et al.
EUROPEAN JOURNAL OF RADIOLOGY (2009)
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
J. Compston et al.
MATURITAS (2009)
Differences in persistence among different weekly oral bisphosphonate medications
O. Sheehy et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Ten-year fracture probability identifies women who will benefit from clodronate therapy-additional results from a double-blind, placebo-controlled randomised study
E. V. McCloskey et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women
K. Lippuner et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis
Johann D. Ringe et al.
RHEUMATOLOGY INTERNATIONAL (2009)
The cost-effectiveness of alendronate in the management of osteoporosis
John A. Kanis et al.
BONE (2008)
A reference standard for the description of osteoporosis
John A. Kanis et al.
BONE (2008)
Commentary: A revised clinician's guide to the prevention and treatment of osteoporosis
Bess Dawson-Hughes
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Cost-effective osteoporosis treatment thresholds: the United States perspective
A. N. A. Tosteson et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
B. Dawson-Hughes et al.
OSTEOPOROSIS INTERNATIONAL (2008)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Case finding for the management of osteoporosis with FRAX® -: assessment and intervention thresholds for the UK
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Simulation-based cost-utility analysis of population screening-based alendronate use in Switzerland
M. Schwenkglenks et al.
OSTEOPOROSIS INTERNATIONAL (2007)
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2007)
A systematic review of persistence and compliance with bisphosphonates for osteoporosis
J. A. Cramer et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Incidence of hip fracture over a 10-year period (1991-2000): Reversal of a secular trend
T. Chevalley et al.
BONE (2007)
Cost-effectiveness of the treatment and prevention of osteoporosis - a review of the literature and a reference model
N. Zethraeus et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial
Dennis M. Black et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
At what hip fracture risk is it cost-effective to treat?: International intervention thresholds for the treatment of osteoporosis
F. Borgstroem et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women ≥70 years of age:: Comparison of three technologically different bone ultrasound devices in the SEMOF study
Marc-Antoine Krieg et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
The cost-effectiveness of risedronate in the treatment of osteoporosis:: an international perspective
F. Borgstrom et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Costs and quality of life associated with osteoporosis-related fractures in Sweden
F Borgström et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective?
Kerrie M. Sanders et al.
BONE (2006)
The population burden of fractures originates in women with osteopenia, not osteoporosis
J. A. Pasco et al.
OSTEOPOROSIS INTERNATIONAL (2006)
A model of osteoporosis impact in Switzerland 2000-2020
M Schwenkglenks et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland
Kurt Lippuner et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Nonagenarians and centenarians in Switzerland, 1860 2001: a demographic analysis
JM Robine et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2005)
Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Intervention thresholds for osteoporosis in the UK
JA Kanis et al.
BONE (2005)
Excess mortality after hospitalisation for vertebral fracture
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Use of cost-effectiveness analysis in health-care resource allocation decision-making:: How are cost-effectiveness thresholds expected to emerge?
HG Eichler et al.
VALUE IN HEALTH (2004)
Mortality after osteoporotic fractures
O Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2004)
The risk and burden of vertebral fractures in Sweden
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Bone mineral density thresholds for pharmacological intervention to prevent fractures
ES Siris et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal
YZ Bagger et al.
BONE (2003)
Diagnosis of osteoporosis and assessment of fracture risk
JA Kanis
LANCET (2002)
Survival and potential years of life lost after hip fracture in men and age-matched women
A Trombetti et al.
OSTEOPOROSIS INTERNATIONAL (2002)
An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture
T Chevalley et al.
OSTEOPOROSIS INTERNATIONAL (2002)
Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women - Results from the National Osteoporosis Risk Assessment
ES Siris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
The burden of osteoporotic fractures: A method for setting intervention thresholds
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2001)
Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis
JA Kanis et al.
BONE (2000)
Long-term risk of osteoporotic fracture in Malmo
JA Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2000)
分享论文
